Caterina F. Ramogida

Author

Also Known As

C F Ramogida, C Ramogida, C. F. Ramogida, C. Ramogida, C.F. Ramogida, CATERINA RAMOGIDA, Caterina F Ramogida, Caterina F. Ramogida, Caterina Fortunata Ramogida, Caterina Ramogida

152

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

TRIUMF University of British Columbia Simon Fraser University Cornell University University of Wisconsin–Madison

About

Caterina F. Ramogida is an author at TRIUMF specializing in engineering, chemistry, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	8	8	326
2	Natural Sciences	5	5	127
3	Medicine	4	4	158
4	Health Sciences	2	2	56
5	Allergy	1	1	14

Caterina F. Ramogida

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy Nikki A. Thiele, Victoria Brown, James M. Kelly, Angewandte Chemie International Edition	2017	249
Influence of the chelate effect on the electronic structure of one-electron oxidized group 10 metal(ii)-(disalicylidene)diamine complexes Yuichi Shimazaki, Natsumi Arai, Tim J. Dunn, Dalton Transactions Inorganic ChemistryChemical EngineeringGroup 10EngineeringCoordination Complex	2011	99
Production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair Brooke L. McNeil, Andrew K. H. Robertson, Winnie Fu, EJNMMI Radiopharmacy and Chemistry	2021	91
H<sub>4</sub>octapa-Trastuzumab: Versatile Acyclic Chelate System for <sup>111</sup>In and <sup>177</sup>Lu Imaging and Therapy Eric W. Price, Brian M. Zeglis, Jacqueline F. Cawthray, Journal of the American Chemical Society EngineeringOncologic ImagingH4octapa-trastuzumab ConjugatesImmunotherapeuticsTumor Biology	2013	88
Octadentate Picolinic Acid‐Based Bispidine Ligand for Radiometal Ions Peter Comba, Una Jermilova, Chris Orvig, Chemistry - A European Journal	2017	81
Multi-isotope SPECT imaging of the<sup>225</sup>Ac decay chain: feasibility studies Andrew K. H. Robertson, Caterina F. Ramogida, Cristina Rodríguez‐Rodríguez, Physics in Medicine and Biology	2017	68
H<sub>2</sub><i>CHX</i>dedpa and H<sub>4</sub><i>CHX</i>octapa—Chiral Acyclic Chelating Ligands for <sup>67/68</sup>Ga and <sup>111</sup>In Radiopharmaceuticals Caterina F. Ramogida, Jacqueline F. Cawthray, Eszter Boros, Inorganic Chemistry	2015	64
Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225Ac Caterina F. Ramogida, Andrew K. H. Robertson, Una Jermilova, EJNMMI Radiopharmacy and Chemistry	2019	64
Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes Aohan Hu, Eduardo Aluicio‐Sarduy, Victoria Brown, Journal of the American Chemical Society	2021	55
Tuning the Kinetic Inertness of Bi<sup>3+</sup> Complexes: The Impact of Donor Atoms on Diaza-18-Crown-6 Ligands as Chelators for <sup>213</sup>Bi Targeted Alpha Therapy David J. Fiszbein, Victoria Brown, Nikki A. Thiele, Inorganic Chemistry	2021	48

Page 1